Swedish Orphan Biovitrum ... (BIOVF)

PNK: BIOVF · Real-Time Price · USD

30.50

-0.16 (-0.51%)

At close: May 02, 2025, 11:30 AM

Swedish Orphan Biovitrum AB (publ) Income Statement

Financials in SEK. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	6.46B	7.44B	6.89B	5.44B	6.26B	6.84B	5.17B	4.87B	5.24B	5.99B	4B	3.88B	4.92B	4.9B	3.76B	3.21B	3.66B	4.58B	2.97B	3.07B	4.64B	4.89B	2.93B	3.16B	3.27B	2.57B	2.31B	2.29B	1.96B	1.87B	1.6B	1.64B	1.4B	1.29B	1.17B	1.47B	1.27B
Cost of Revenue	1.59B	1.6B	1.33B	2.15B	1.55B	2.38B	1.17B	1.37B	1.07B	1.31B	932M	1.02B	1.52B	1.02B	959M	783M	726M	863M	632M	689M	1.04B	1.06B	757M	750M	771M	677.43M	574M	612M	552M	538M	473M	475M	368M	431.82M	389M	404M	329M
Gross Profit	4.88B	5.84B	5.56B	3.29B	4.71B	4.46B	4B	3.5B	4.17B	4.68B	3.07B	2.86B	3.41B	3.88B	2.8B	2.43B	2.94B	3.72B	2.34B	2.38B	3.6B	3.83B	2.17B	2.41B	2.49B	1.89B	1.74B	1.68B	1.41B	1.34B	1.13B	1.16B	1.03B	859.52M	782M	1.06B	944M
Operating Income	1.36B	1.66B	2.04B	640M	1.31B	1.6B	547M	413M	1.5B	1.92B	699M	323M	776M	1.52B	708M	467M	1.03B	2.12B	464M	541M	1.7B	1.87B	754M	677M	1.23B	801.97M	820M	841M	660M	508.37M	426M	381M	284M	99.11M	171M	453M	410M
Interest Income	n/a	n/a	n/a	n/a	n/a	345M	n/a	n/a	170M	111M	n/a	105M	n/a	n/a	n/a	112M	n/a	n/a	n/a	182M	n/a	n/a	n/a	50M	n/a	n/a	n/a	n/a	3M	54.22M	n/a	n/a	n/a	74.43M	n/a	n/a	n/a
Pretax Income	1.1B	1.44B	1.71B	275M	982M	1.24B	116M	275M	1.32B	1.77B	564M	317M	674M	1.42B	598M	354M	919M	1.94B	366M	358M	1.56B	1.76B	697M	632M	1.15B	778.74M	807M	834M	662M	494.42M	409M	360M	269M	86.98M	149M	425M	387M
Net Income	875M	1.4B	1.46B	224M	800M	1.03B	94M	222M	1.07B	1.39B	451M	258M	543M	1.24B	473M	268M	696M	1.5B	278M	283M	1.18B	1.36B	542M	499M	903M	594.79M	623M	685M	515M	357.61M	324M	246M	196M	99.07M	143M	265M	301M
Selling & General & Admin	1.78B	3.19B	1.81B	1.75B	2.57B	2.08B	2.66B	2.48B	2.03B	2.12B	1.83B	1.32B	2.05B	1.82B	1.57B	1.47B	1.43B	1.55B	1.42B	1B	1.54B	1.59B	1.14B	860M	985M	750.74M	622M	594M	544M	588.75M	481M	524M	504M	511.58M	438M	422M	407M
Research & Development	834M	981M	845M	898M	814M	777M	746M	548M	645M	643M	526M	607M	578M	554M	485M	484M	471M	486M	405M	345M	359M	357M	293M	513M	332M	328.42M	287M	241M	233M	228.72M	214M	247M	218M	257.59M	179M	202M	138M
Other Expenses	908M	3M	871M	-3M	n/a	n/a	n/a	61M	7M	-29M	8M	507M	2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	25M	n/a	n/a	n/a	n/a	-27.3M	6M	12M	11M
Operating Expenses	3.52B	4.17B	3.52B	2.65B	3.39B	2.86B	3.45B	3.09B	2.68B	2.73B	2.37B	2.43B	2.63B	2.3B	2.09B	1.96B	1.9B	1.96B	1.88B	1.84B	1.9B	1.99B	1.42B	1.74B	1.27B	1.09B	921M	836M	752M	777.2M	703M	782M	743M	796.73M	611M	612M	534M
Interest Expense	n/a	n/a	n/a	337M	n/a	n/a	431M	138M	n/a	n/a	135M	n/a	102M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	24.03M	n/a	21M	n/a	23.43M	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	2.63B	2.57B	-917M	n/a	2.48B	2.03B	n/a	1.83B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1B	n/a	n/a	n/a	860M	985M	750.74M	622M	594M	544M	587.47M	481M	524M	504M	509.26M	438M	422M	407M
Cost & Expenses	5.11B	5.77B	4.86B	4.8B	4.94B	5.24B	4.62B	4.46B	3.75B	4.04B	3.3B	3.45B	4.15B	3.32B	3.05B	2.74B	2.63B	2.82B	2.51B	2.53B	2.94B	3.05B	2.18B	2.48B	2.04B	1.77B	1.5B	1.45B	1.3B	1.32B	1.18B	1.26B	1.11B	1.23B	1B	1.02B	863M
Income Tax Expense	221M	47M	248M	51M	182M	211M	22M	54M	258M	380M	113M	60M	131M	182M	125M	87M	223M	434M	88M	75M	375M	402M	155M	133M	251M	183.94M	183M	149M	148M	136.81M	85M	115M	74M	-12.09M	6M	159M	86M
Shares Outstanding (Basic)	343.45M	343.23M	343.01M	340.59M	339.83M	339.57M	315.93M	310.62M	310.18M	309.89M	298.68M	297.98M	296.72M	295.05M	295.14M	295.01M	294.9M	294.66M	294.9M	294.74M	294.3M	292.65M	294.28M	294.09M	287.91M	269.52M	269.68M	269.26M	269.26M	269.91M	269.12M	269.01M	268.78M	268.36M	268.75M	268.3M	267.63M
Shares Outstanding (Diluted)	346.97M	347.06M	346.84M	344.75M	344.07M	342.88M	318.8M	313.9M	313.39M	312.87M	298.72M	297.98M	297.48M	296.9M	296.65M	296.02M	298.73M	297.88M	297.45M	297M	297.13M	296.18M	295.9M	295.49M	289.27M	270.42M	270.6M	270.79M	270.33M	270.49M	269.93M	270.09M	269.72M	269.26M	269.04M	269.17M	269.55M
EPS (Basic)	2.55	4.07	4.27	0.66	2.35	3.02	0.30	0.71	3.44	4.47	1.51	0.87	1.83	4.21	1.60	0.91	2.36	5.10	0.94	0.96	4.02	4.65	1.84	1.70	3.14	2.21	2.31	2.54	1.91	1.32	1.20	0.91	0.73	0.37	0.53	0.99	1.12
EPS (Diluted)	2.52	4.03	4.22	0.65	2.33	2.99	0.29	0.74	3.56	4.43	1.51	0.87	1.83	4.18	1.59	0.91	2.33	5.04	0.93	0.95	3.98	4.59	1.83	1.69	3.12	2.20	2.30	2.53	1.91	1.32	1.20	0.91	0.73	0.37	0.53	0.98	1.12
EBITDA	2.3B	2.59B	2.96B	1.55B	2.38B	2.6B	1.48B	1.05B	2.16B	2.47B	1.28B	888M	1.99B	2.04B	1.2B	957M	1.52B	2.46B	972M	1.05B	2.2B	2.3B	1.13B	1.06B	1.54B	940.77M	942M	954M	780M	623.37M	543M	499M	415M	212.24M	288M	557M	510M
EBIT	1.36B	1.66B	2.04B	612M	1.31B	1.61B	548M	414M	1.49B	1.88B	699M	423M	776M	1.51B	708M	363M	1.03B	1.97B	464M	540M	1.7B	1.83B	753M	636M	1.23B	818.2M	820M	834M	660M	504.39M	426M	381M	285M	93.53M	171M	453M	410M
Depreciation & Amortization	938M	932M	924M	915M	909M	997M	936M	637M	664M	590M	579M	565M	553M	536M	494M	490M	485M	330M	509M	510M	507M	263M	379M	408M	312M	122.58M	122M	120M	120M	118.98M	118M	118M	130M	118.71M	117M	104M	100M